Analyst Consensus ?
ConsensusHold37 ratings
Bullish1951.4%
Neutral1643.2%
Bearish25.4%
FN2 Earnings Intelligence
Norwegian Cruise Line Holdings Ltd. (NCLH) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 30, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| JP Morgan | Underweight | Neutral | Downgrade | Oct 23, 2026 |
| TD Cowen | Buy | Buy | Maintain | Oct 20, 2026 |
| Susquehanna | Neutral | Neutral | Maintain | Oct 20, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Oct 12, 2026 |
| Citigroup | Buy | Buy | Maintain | Oct 2, 2026 |
| Truist Securities | Hold | Hold | Maintain | Sep 24, 2026 |
| UBS | Neutral | Neutral | Maintain | Aug 18, 2026 |
| Mizuho | Neutral | Outperform | Downgrade | Aug 18, 2026 |
| Stifel | Buy | Buy | Maintain | Jul 31, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Jul 31, 2026 |
| Jefferies | Hold | Hold | Maintain | Jul 17, 2026 |
| Goldman Sachs | Neutral | Neutral | Maintain | Jul 14, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Jul 9, 2026 |
| Tigress Financial | Strong Buy | Strong Buy | Maintain | Apr 17, 2026 |
| B of A Securities | Neutral | Neutral | Maintain | Mar 3, 2026 |
| Macquarie | Outperform | Outperform | Maintain | May 9, 2025 |
| Loop Capital | Buy | Buy | Maintain | May 1, 2025 |
| Argus Research | Buy | Hold | Upgrade | Nov 4, 2024 |
| Deutsche Bank | Hold | Hold | Maintain | Nov 1, 2024 |
| Redburn Partners | Buy | Neutral | Upgrade | Sep 14, 2023 |
| Credit Suisse | Neutral | Neutral | Maintain | May 2, 2023 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Jun 16, 2021 |
| Berenberg | Hold | Buy | Downgrade | Feb 12, 2021 |
| SunTrust Robinson Humphrey | Hold | Buy | Downgrade | Jul 14, 2020 |
| Redburn | Neutral | Buy | Downgrade | Jun 22, 2020 |
| Nomura | Buy | Buy | Maintain | Apr 8, 2020 |
| CFRA | Sell | Strong Sell | Maintain | Mar 2, 2020 |
| Wedbush | Outperform | Outperform | Maintain | Feb 21, 2020 |
| Stifel Nicolaus | Buy | Buy | Maintain | Feb 21, 2020 |
| Buckingham Research | Buy | Buy | Maintain | Nov 8, 2019 |
| Buckingham | Buy | Buy | Maintain | Nov 8, 2019 |
| Bank of America | Buy | Buy | Maintain | Aug 9, 2019 |
| Bernstein | Outperform | Market Perform | Upgrade | Jan 8, 2019 |
| Argus | Buy | Buy | Maintain | Oct 25, 2017 |
| Sterne Agee CRT | Buy | Buy | Maintain | Jun 7, 2016 |
| DNB Markets | Hold | Buy | Downgrade | Dec 18, 2014 |
| Longbow Research | Neutral | Buy | Downgrade | Jun 4, 2014 |
Upside is calculated against the persisted current price $18.22. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Susquehanna | Christopher Stathoulopoulos | $16 | $15.24 | -12.2% | Oct 20, 2026 |
| Truist Financial | Patrick Scholes | $16 | $14.17 | -12.2% | Sep 24, 2026 |
| Canaccord Genuity | Joseph Vafi | $45 | $18.18 | +147.0% | Aug 18, 2026 |
| UBS | Analyst unavailable | $20 | $18.18 | +9.8% | Aug 18, 2026 |
| Mizuho Securities | Ben Chaiken | $17 | $18.18 | -6.7% | Aug 18, 2026 |
| Susquehanna | Analyst unavailable | $17 | $19.82 | -6.7% | Aug 4, 2026 |
| Deutsche Bank | Analyst unavailable | $17 | $18.47 | -6.7% | Jul 31, 2026 |
| Mizuho Securities | Analyst unavailable | $22 | $18.72 | +20.7% | Jul 31, 2026 |
| Barclays | Analyst unavailable | $18 | $18.72 | -1.2% | Jul 31, 2026 |
| Jefferies | Analyst unavailable | $18 | $19.61 | -1.2% | Jul 17, 2026 |
| Goldman Sachs | Lizzie Dove | $16 | $19.63 | -12.2% | Jul 14, 2026 |
| Morgan Stanley | Analyst unavailable | $22 | $19.14 | +20.7% | Jul 9, 2026 |
| BMO Capital | Tristan Thomas-Martin | $21 | $18.83 | +15.3% | Jul 7, 2026 |
| Wells Fargo | Analyst unavailable | $25 | $21.11 | +37.2% | Jul 1, 2026 |
| Bernstein | Richard Clarke | $18 | $18.13 | -1.2% | Jun 3, 2026 |
| Loop Capital Markets | Analyst unavailable | $22 | $18.34 | +20.7% | Jun 1, 2026 |
| UBS | Robin Farley | $17 | $14.94 | -6.7% | May 19, 2026 |
| Deutsche Bank | Analyst unavailable | $18 | $17.34 | -1.2% | May 5, 2026 |
| Susquehanna | Analyst unavailable | $15 | $17.2 | -17.7% | May 5, 2026 |
| Morgan Stanley | Analyst unavailable | $20 | $17.2 | +9.8% | May 5, 2026 |
| Goldman Sachs | Analyst unavailable | $14 | $17.2 | -23.2% | May 5, 2026 |
| Barclays | Analyst unavailable | $19 | $17.2 | +4.3% | May 5, 2026 |
| Wells Fargo | Analyst unavailable | $26 | $21.09 | +42.7% | Apr 15, 2026 |
| Barclays | Analyst unavailable | $21 | $19.76 | +15.3% | Apr 10, 2026 |
| Morgan Stanley | Stephen Grambling | $23 | $19.96 | +26.2% | Apr 9, 2026 |
| Mizuho Securities | Analyst unavailable | $27 | $20.16 | +48.2% | Apr 8, 2026 |
| Wolfe Research | Greg Badishkanian | $25 | $22.18 | +37.2% | Mar 3, 2026 |
| Stifel Nicolaus | Steven Wieczynski | $30 | $22.18 | +64.7% | Mar 3, 2026 |
| Morgan Stanley | Stephen Grambling | $25 | $22.18 | +37.2% | Mar 3, 2026 |
| Needham | Analyst unavailable | $27 | $22.18 | +48.2% | Mar 3, 2026 |
| Goldman Sachs | Lizzie Dove | $20 | $22.18 | +9.8% | Mar 3, 2026 |
| Mizuho Securities | Ben Chaiken | $28 | $22.18 | +53.7% | Mar 2, 2026 |
| Stifel Nicolaus | Steven Wieczynski | $31 | $23.56 | +70.1% | Feb 11, 2026 |
| Wells Fargo | Analyst unavailable | $33 | $24.34 | +81.1% | Jan 13, 2026 |
| Barclays | Analyst unavailable | $23 | $21.54 | +26.2% | Dec 17, 2025 |
| Jefferies | Analyst unavailable | $20 | $20.86 | +9.8% | Dec 15, 2025 |
| Mizuho Securities | Analyst unavailable | $32 | $20.56 | +75.6% | Dec 12, 2025 |
| Goldman Sachs | Analyst unavailable | $21 | $19.11 | +15.3% | Dec 9, 2025 |
| Truist Financial | Analyst unavailable | $26 | $18.57 | +42.7% | Dec 2, 2025 |
| Susquehanna | Christopher Stathoulopoulos | $21 | $18.82 | +15.3% | Nov 12, 2025 |
| Goldman Sachs | Analyst unavailable | $27 | $18.4 | +48.2% | Nov 5, 2025 |
| Barclays | Brandt Montour | $28 | $18.79 | +53.7% | Nov 5, 2025 |
| Truist Financial | Patrick Scholes | $31 | $25.41 | +70.1% | Sep 19, 2025 |
| Tigress Financial | Ivan Feinseth | $38 | $24.74 | +108.6% | Aug 27, 2025 |
| UBS | Analyst unavailable | $27 | $24.45 | +48.2% | Aug 26, 2025 |
| Goldman Sachs | Lizzie Dove | $34 | $26.42 | +86.6% | Jan 23, 2025 |
| Truist Financial | Patrick Scholes | $35 | $28.4 | +92.1% | Dec 2, 2024 |
| Tigress Financial | Ivan Feinseth | $36 | $27.82 | +97.6% | Nov 11, 2024 |
| Macquarie | Paul Golding | $30 | $24.88 | +64.7% | Nov 1, 2024 |
| Morgan Stanley | Stephen Grambling | $19 | $23.96 | +4.3% | Oct 30, 2024 |
| Barclays | Brandt Montour | $26 | $23.71 | +42.7% | Oct 22, 2024 |
| Citigroup | James Hardiman | $30 | $23.07 | +64.7% | Oct 9, 2024 |
| Stifel Nicolaus | Steven Wieczynski | $29 | $20.39 | +59.2% | Oct 4, 2024 |
| Mizuho Securities | Ben Chaiken | $26 | $17.94 | +42.7% | Sep 11, 2024 |
| Truist Financial | Patrick Scholes | $21 | $16.56 | +15.3% | May 29, 2024 |
| Mizuho Securities | Ben Chaiken | $24 | $16 | +31.7% | May 28, 2024 |
| Deutsche Bank | Chris Woronka | $20 | $16.94 | +9.8% | May 21, 2024 |
| Barclays | Brandt Montour | $20 | $16.94 | +9.8% | May 21, 2024 |
| UBS | Robin Farley | $19 | $16.94 | +4.3% | May 21, 2024 |
| Wells Fargo | Daniel Politzer | $20 | $16.94 | +9.8% | May 21, 2024 |
| Stifel Nicolaus | Steven Wieczynski | $26 | $16.94 | +42.7% | May 21, 2024 |
| Wells Fargo | Daniel Politzer | $19 | $16.08 | +4.3% | May 2, 2024 |
| Stifel Nicolaus | Steven Wieczynski | $25 | $19.17 | +37.2% | Apr 9, 2024 |
| Mizuho Securities | Ben Chaiken | $21 | $20.54 | +15.3% | Mar 25, 2024 |
| Goldman Sachs | Lizzie Dove | $19 | $19.87 | +4.3% | Mar 13, 2024 |
| Redburn Partners | Alex Brignall | $25 | $15.18 | +37.2% | Sep 25, 2023 |
| Morgan Stanley | Analyst unavailable | $11.5 | $13.75 | -36.9% | Jan 10, 2023 |
| UBS | Analyst unavailable | $13 | $13.8 | -28.6% | Jan 9, 2023 |
| UBS | Analyst unavailable | $19 | $15.46 | +4.3% | Dec 13, 2022 |
| J.P. Morgan | Analyst unavailable | $30 | $15.64 | +64.7% | Dec 6, 2022 |
| Truist Financial | Analyst unavailable | $21 | $16.12 | +15.3% | Nov 22, 2022 |
| Credit Suisse | Analyst unavailable | $14 | $17.59 | -23.2% | Nov 17, 2022 |
| UBS | Analyst unavailable | $24 | $17.87 | +31.7% | Nov 14, 2022 |
| Tigress Financial | Ivan Feinseth | $32 | $14.62 | +75.6% | Oct 21, 2022 |
| Morgan Stanley | Thomas Allen | $13 | $14.16 | -28.6% | Aug 12, 2022 |
| Morgan Stanley | Thomas Allen | $14 | $11.43 | -23.2% | Jun 20, 2022 |
| Susquehanna | Christopher Stathoulopoulos | $20 | $11.43 | +9.8% | Jun 18, 2022 |
| Morgan Stanley | Thomas Allen | $18 | $16.14 | -1.2% | May 13, 2022 |
| Citigroup | Analyst unavailable | $24 | $22.22 | +31.7% | Apr 19, 2022 |
| Truist Financial | Patrick Scholes | $20 | $19.86 | +9.8% | Mar 25, 2022 |
| Macquarie | Paul Golding | $23 | $17.39 | +26.2% | Mar 4, 2022 |
| Citigroup | James Ainley | $25 | $22.63 | +37.2% | Feb 10, 2022 |
| J.P. Morgan | Brandt Montour | $37 | $24.66 | +103.1% | Aug 9, 2021 |
| UBS | Robin M. Farley | $29 | $27.66 | +59.2% | May 11, 2021 |
| Goldman Sachs | Stephen Grambling | $37 | $26.75 | +103.1% | Apr 20, 2021 |
Track every rating change on NCLH the moment it posts. Free to start.
Start freeOne email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.